The Rodenstock Group is to be acquired by Apax Funds, a global private equity advisory firm that invests in companies across four sectors of healthcare, technology, services and internet/consumer.
Apax will acquire the German manufacturer from Compass Partners, and has stated its intention to support Rodenstock’s management team’s vision of accelerating the company’s growth through innovation, commercial execution and digitisation, while continuing to deliver the highest level of service to clients and partners. The Apax Healthcare team has a deep understanding of innovative MedTech through prior investments in the space.
Anders Hedegaard, CEO of Rodenstock said, “We are excited to partner with the Apax Funds, who have a proven culture of investing for growth, and who will be able to support Rodenstock’s continued quest to develop and produce the highest quality lenses for our customers. During 2020 we saw tremendous growth driven by our B.I.G. VISION technology, which helped us emerge from the Covid-19 crisis stronger than most of our competitors. Our innovative technology enhances the value proposition that can be delivered by our opticians, who in turn are delivering optimal vision to consumers. With the support of Apax we are looking to expand our presence even further by offering our customers more excellent and innovative products.”
The transaction is subject to applicable regulatory approvals and is expected to close in the middle of 2021. Financial terms were not disclosed.
